
DarioHealth Corp. DRIO
$ 7.96
2.58%
Annual report 2025
added 03-19-2026
DarioHealth Corp. Current Ratio 2011-2026 | DRIO
Annual Current Ratio DarioHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 4.85 | 4.39 | 2.58 | 2.01 | 1 | 2.54 | 1.27 | 1.95 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.85 | 1 | 2.57 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 464.9 | 0.9 % | $ 13.4 B | ||
|
Biodesix
BDSX
|
1.27 | $ 15.0 | -3.47 % | $ 1.95 B | ||
|
Biomerica
BMRA
|
3.23 | $ 2.13 | -1.54 % | $ 4.89 M | ||
|
Bioventus
BVS
|
1.5 | $ 9.26 | 1.15 % | $ 617 M | ||
|
DexCom
DXCM
|
1.76 | $ 66.59 | -0.02 % | $ 26 B | ||
|
Mettler-Toledo International
MTD
|
0.994 | $ 1 269.13 | 0.28 % | $ 26.2 B | ||
|
Neogen Corporation
NEOG
|
2.51 | $ 9.33 | 2.41 % | $ 2.02 B | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Guardant Health
GH
|
0.953 | $ 85.95 | 2.82 % | $ 10.8 B | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
1.12 | $ 17.39 | -0.29 % | $ 389 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Natera
NTRA
|
2.02 | $ 198.9 | 2.25 % | $ 19.6 B | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Pacific Biosciences of California
PACB
|
1.01 | $ 1.41 | 1.08 % | $ 423 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Precipio
PRPO
|
4.93 | $ 29.06 | 9.25 % | $ 37.7 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
RadNet
RDNT
|
1.56 | $ 60.99 | 1.87 % | $ 4.59 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 163.49 | 2.68 % | $ 8.1 B | ||
|
IQVIA Holdings
IQV
|
1.28 | $ 166.64 | 0.3 % | $ 28.6 B | ||
|
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 4.71 | 2.17 % | $ 436 M | ||
|
Senseonics Holdings
SENS
|
1.94 | $ 6.75 | 1.35 % | $ 282 M | ||
|
Sotera Health Company
SHC
|
1.23 | $ 13.89 | 0.36 % | $ 3.94 B | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Soleno Therapeutics
SLNO
|
4.96 | $ 32.6 | 4.02 % | $ 1.66 B | ||
|
Interpace Biosciences
IDXG
|
0.87 | $ 1.71 | - | $ 7.5 M | ||
|
Neuronetics
STIM
|
1.23 | $ 1.41 | -3.09 % | $ 93 M | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Personalis
PSNL
|
4.02 | $ 8.15 | 4.69 % | $ 483 M | ||
|
Celcuity
CELC
|
1.89 | $ 109.36 | 7.21 % | $ 4.31 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.8 | 0.25 % | $ 22.2 B | ||
|
ENDRA Life Sciences
NDRA
|
2.35 | $ 3.5 | 1.2 % | $ 1.88 M | ||
|
NeoGenomics
NEO
|
2.6 | $ 7.93 | 0.89 % | $ 1.02 B | ||
|
Thermo Fisher Scientific
TMO
|
1.92 | $ 490.67 | 0.13 % | $ 185 B |